LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.
Under applicable securities laws, insiders are subject to limits on their ability to sell shares. ASDPs permit trades to be made in accordance with pre-arranged instructions given when the insider is not in possession of any material undisclosed information, on an automatic basis, regardless of any subsequent material non-public information the insider receives. Once an ASDP is established, the insider is not permitted to exercise any further discretion or influence over how dispositions will occur under the ASDP.
The ASDP was established in accordance with applicable United States and Canadian securities laws and Viemed's internal policies. The ASDP consists of a pre-arranged trading plan administered by Morgan Stanley Smith Barney LLC ("Morgan Stanley") pursuant to Rule 10b5-1 under the U.S. Securities Exchange Act of 1934 with respect to common shares of Viemed held by Moore Faster LLC, an entity controlled by Mr. Moore. Mr. Moore has provided pre-arranged instructions in writing to Morgan Stanley. The ASDP prohibits Mr. Moore from disclosing to Morgan Stanley any information concerning the Company that might influence the execution of the ASDP.
The ASDP was adopted in accordance with Viemed's insider trading policy and at a time when Mr. Moore was not aware of any material fact or material change relating to Viemed that had not been generally disclosed.
Up to 246,000 common shares may be sold under the ASDP pursuant to predetermined trading instructions over an approximately one-year term ending November 30, 2027. The shares subject to the ASDP represent less than 11% of the common shares beneficially owned directly and indirectly by Mr. Moore as disclosed in the Company's most recent proxy statement. Sales may commence as early as December 24, 2026, following the applicable waiting period under Rule 10b5-1. Sales under the ASDP are subject to a minimum floor price.
The arrangement has been authorized by the Company and contains meaningful restrictions on the ability of Mr. Moore and Moore Faster LLC to amend, suspend or terminate the ASDP. Any amendment, suspension or termination of the ASDP will be disclosed in accordance with applicable securities laws.